Production (Stage)
Bicycle Therapeutics plc
BCYC
$8.05
-$0.05-0.62%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -60.75M | -51.85M | -50.80M | -39.81M | -26.56M |
| Total Depreciation and Amortization | 1.63M | 1.70M | 2.17M | 1.64M | 1.66M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8.29M | 4.82M | 7.88M | 9.26M | 8.62M |
| Change in Net Operating Assets | -35.54M | 35.93M | 921.00K | -15.72M | -54.58M |
| Cash from Operations | -86.37M | -9.40M | -39.83M | -44.63M | -70.87M |
| Capital Expenditure | -604.00K | -368.00K | -435.00K | -420.00K | -12.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -604.00K | -368.00K | -435.00K | -420.00K | -12.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -43.00K | -42.00K | -31.86M | -- | -- |
| Issuance of Common Stock | 2.00K | 245.00K | -- | 549.61M | 1.87M |
| Repurchase of Common Stock | -- | -- | -67.00K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -41.00K | 203.00K | -31.93M | 549.61M | 1.87M |
| Foreign Exchange rate Adjustments | 468.00K | -1.78M | 1.70M | -192.00K | -416.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -86.55M | -11.34M | -70.50M | 504.37M | -69.43M |